{
    "PMC5564609_3": [
        {
            "subject": {
                "parameter": "Delayed gastric emptying",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.02"
            },
            "measures": "[15, 32]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Bleeding",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.5"
            },
            "measures": "[6, 4]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Pancreatic fistula",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.52"
            },
            "measures": "[39, 36]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Grade A Pancreatic fistula",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83"
            },
            "measures": "[8, 6]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Grade B Pancreatic fistula",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83"
            },
            "measures": "[10, 6]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Grade C Pancreatic fistula",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83"
            },
            "measures": "[21, 24]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Biliary fistula",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.47"
            },
            "measures": "[2, 0]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Wound infection",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.66"
            },
            "measures": "[5, 3]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Pulmonary complication",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.1"
            },
            "measures": "[2, 4]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Skin orifice infection",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.012"
            },
            "measures": "[1, 6]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Abdominal abscess",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "/"
            },
            "measures": "[0, 0]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Pancreatitis",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "1"
            },
            "measures": "[2, 1]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Sepsis",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "1"
            },
            "measures": "[1, 0]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Re-laparotomy",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "0.6"
            },
            "measures": "[3, 1]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Mortality",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "/"
            },
            "measures": "[0, 0]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        },
        {
            "subject": {
                "parameter": "Readmission (in 30 days)",
                "group": "ERAS",
                "sample_size": "76",
                "comparison_group": "Conventional",
                "comparison_sample_size": "83",
                "statistical_test": "Fisher exact test",
                "p_value": "1"
            },
            "measures": "[1, 1]",
            "outcomes": "[outcome_ERAS, outcome_Conventional]"
        }
    ],
    "PMC3798558_1": [
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "p_value": "0.999"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "age_range": "<40"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[5.41, 5.12]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "age_range": "\u226540 but <50"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[10.27, 10.03]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "age_range": "\u226550 but <60"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[32.43, 32.70]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "age_range": "\u226560 but <70"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[32.43, 33.04]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Age",
                "age_range": "\u226570"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[19.46, 19.11]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Sex",
                "p_value": "0.068"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Sex",
                "sex": "Male"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[68.65, 74.88]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Sex",
                "sex": "Female"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[31.35, 25.12]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "p_value": "0.021"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "<18.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[8.11, 4.16]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "\u226518.5 but <22.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[45.11, 37.88]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "\u226522.5 but <25"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[25.41, 32.63]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "\u226525 but <27.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[13.51, 16.72]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "\u226527.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[7.57, 7.58]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Current BMI (kg/m2)",
                "bmi_range": "Unknown"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[0.00, 1.02]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "p_value": "0.018"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "<18.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[7.57, 11.47]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "\u226518.5 but <22.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[60.54, 64.85]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "\u226522.5 but <25"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[19.46, 15.43]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "\u226525 but <27.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[5.95, 4.91]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "\u226527.5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[3.24, 0.96]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "BMI at age 20 (kg/m2)",
                "bmi_range": "Unknown"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[3.24, 2.39]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "p_value": "0.005"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "pack_years_range": "<5"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[37.30, 43.55]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "pack_years_range": "\u22655 but <20"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[11.89, 14.06]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "pack_years_range": "\u226520 but <40"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[18.38, 21.02]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "pack_years_range": "\u226540"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[32.43, 20.75]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Cigarette pack-years",
                "pack_years_range": "Unknown"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[0.00, 0.61]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "p_value": "0.568"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "drinking_range": "Non"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[30.27, 33.31]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "drinking_range": "<23"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[28.65, 29.01]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "drinking_range": "\u226523 but <46"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[23.24, 23.34]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "drinking_range": "\u226546"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[16.76, 13.17]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Drinking, g ethanol/day",
                "drinking_range": "Unknown"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[1.08, 1.16]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "History of diabetes mellitus",
                "p_value": "<0.001"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "History of diabetes mellitus",
                "diabetes_status": "Yes"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[20.00, 8.60]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "History of diabetes mellitus",
                "diabetes_status": "No"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[80.00, 91.40]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Family history of PC",
                "p_value": "0.811"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Family history of PC",
                "family_history_status": "Yes"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[4.32, 3.96]"
        },
        {
            "subject": {
                "comparison_group": "pancreatic cancer patients vs non-cancer controls",
                "cases_n": "185",
                "controls_n": "1465",
                "characteristic": "Family history of PC",
                "family_history_status": "No"
            },
            "measures": "[cases_percentage, controls_percentage]",
            "outcomes": "[95.68, 96.04]"
        }
    ],
    "PMC5762325_3": [
        {
            "subject": {
                "analysis_type": "correlation analysis",
                "marker1": "E-cadherin",
                "marker2": "STYK1",
                "context": "pancreatic cancer",
                "tumor_tissue_sample": "E-cadherin Low",
                "STYK1_expression_low": "9",
                "STYK1_expression_high": "23",
                "correlation_coefficient": "-0.420",
                "p_value": "<0.001"
            },
            "measures": "[correlation_coefficient, p_value]",
            "outcomes": "[-0.420, <0.001]"
        },
        {
            "subject": {
                "analysis_type": "correlation analysis",
                "marker1": "E-cadherin",
                "marker2": "STYK1",
                "context": "pancreatic cancer",
                "tumor_tissue_sample": "E-cadherin High",
                "STYK1_expression_low": "34",
                "STYK1_expression_high": "14"
            },
            "measures": "[STYK1_expression_low, STYK1_expression_high]",
            "outcomes": "[34, 14]"
        }
    ],
    "PMC3798558_3": [
        {
            "subject": {
                "haplotype": "1",
                "SNP1": "C",
                "SNP2": "G",
                "haplotype_frequency_overall": "0.439",
                "haplotype_frequency_cases": "0.433",
                "haplotype_frequency_controls": "0.442",
                "adjusted_OR": "1.00 (ref.)",
                "P-value": "",
                "gene": "XRCC1",
                "analysis_type": "haplotype-effects logistic regression",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "case_control_data": "185/1465",
                "SNP1_identifier": "rs1799782",
                "SNP2_identifier": "rs25487",
                "R_squared_between_SNPs": "0.15"
            },
            "measures": "[]",
            "outcomes": ""
        },
        {
            "subject": {
                "haplotype": "2",
                "SNP1": "C",
                "SNP2": "A",
                "haplotype_frequency_overall": "0.240",
                "haplotype_frequency_cases": "0.274",
                "haplotype_frequency_controls": "0.239",
                "adjusted_OR": "1.32 (1.01-1.71)",
                "P-value": "0.042",
                "gene": "XRCC1",
                "analysis_type": "haplotype-effects logistic regression",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "case_control_data": "185/1465",
                "SNP1_identifier": "rs1799782",
                "SNP2_identifier": "rs25487",
                "R_squared_between_SNPs": "0.15"
            },
            "measures": "[OR]",
            "outcomes": "[1.32]"
        },
        {
            "subject": {
                "haplotype": "3",
                "SNP1": "T",
                "SNP2": "G",
                "haplotype_frequency_overall": "0.319",
                "haplotype_frequency_cases": "0.292",
                "haplotype_frequency_controls": "0.318",
                "adjusted_OR": "1.05 (0.81-1.36)",
                "P-value": "0.691",
                "gene": "XRCC1",
                "analysis_type": "haplotype-effects logistic regression",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "case_control_data": "185/1465",
                "SNP1_identifier": "rs1799782",
                "SNP2_identifier": "rs25487",
                "R_squared_between_SNPs": "0.15"
            },
            "measures": "[OR]",
            "outcomes": "[1.05]"
        },
        {
            "subject": {
                "haplotype": "4",
                "SNP1": "T",
                "SNP2": "A",
                "haplotype_frequency_overall": "0.002",
                "haplotype_frequency_cases": "<0.001",
                "haplotype_frequency_controls": "0.002",
                "adjusted_OR": "N.E.",
                "P-value": "N.E.",
                "gene": "XRCC1",
                "analysis_type": "haplotype-effects logistic regression",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "case_control_data": "185/1465",
                "SNP1_identifier": "rs1799782",
                "SNP2_identifier": "rs25487",
                "R_squared_between_SNPs": "0.15"
            },
            "measures": "[]",
            "outcomes": ""
        }
    ],
    "PMC4423458_3": [
        {
            "subject": {
                "protein_name": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "molecular_weight_kDa": "56",
                "context": "cancer_vs_control",
                "average_SC_cancer": "138.8",
                "average_SC_control": "52.1",
                "NSAF_ratio": "2.2",
                "p_value_t_test": "0.01481"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[138.8, 52.1, 2.2]"
        },
        {
            "subject": {
                "protein_name": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "molecular_weight_kDa": "67",
                "context": "cancer_vs_control",
                "average_SC_cancer": "37.3",
                "average_SC_control": "11.5",
                "NSAF_ratio": "2.3",
                "p_value_t_test": "0.04311"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[37.3, 11.5, 2.3]"
        },
        {
            "subject": {
                "protein_name": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "molecular_weight_kDa": "69",
                "context": "cancer_vs_control",
                "average_SC_cancer": "986.0",
                "average_SC_control": "332.8",
                "NSAF_ratio": "2.4",
                "p_value_t_test": "0.00006"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[986.0, 332.8, 2.4]"
        },
        {
            "subject": {
                "protein_name": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "molecular_weight_kDa": "53",
                "context": "cancer_vs_control",
                "average_SC_cancer": "51.9",
                "average_SC_control": "19.2",
                "NSAF_ratio": "2.4",
                "p_value_t_test": "0.03919"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[51.9, 19.2, 2.4]"
        },
        {
            "subject": {
                "protein_name": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "molecular_weight_kDa": "48",
                "context": "cancer_vs_control",
                "average_SC_cancer": "21.3",
                "average_SC_control": "5.5",
                "NSAF_ratio": "3.8",
                "p_value_t_test": "0.01109"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[21.3, 5.5, 3.8]"
        },
        {
            "subject": {
                "protein_name": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "molecular_weight_kDa": "163",
                "context": "cancer_vs_control",
                "average_SC_cancer": "127.9",
                "average_SC_control": "29.3",
                "NSAF_ratio": "3.9",
                "p_value_t_test": "0.00618"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[127.9, 29.3, 3.9]"
        },
        {
            "subject": {
                "protein_name": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "molecular_weight_kDa": "45",
                "context": "cancer_vs_control",
                "average_SC_cancer": "83.8",
                "average_SC_control": "18.0",
                "NSAF_ratio": "4.2",
                "p_value_t_test": "0.00024"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[83.8, 18.0, 4.2]"
        },
        {
            "subject": {
                "protein_name": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "molecular_weight_kDa": "52",
                "context": "cancer_vs_control",
                "average_SC_cancer": "89.3",
                "average_SC_control": "17.3",
                "NSAF_ratio": "4.3",
                "p_value_t_test": "0.00133"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[89.3, 17.3, 4.3]"
        },
        {
            "subject": {
                "protein_name": "Complement C3 precursor",
                "accession": "115298678",
                "molecular_weight_kDa": "187",
                "context": "cancer_vs_control",
                "average_SC_cancer": "174.7",
                "average_SC_control": "35.6",
                "NSAF_ratio": "4.3",
                "p_value_t_test": "0.00612"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[174.7, 35.6, 4.3]"
        },
        {
            "subject": {
                "protein_name": "Myeloperoxidase precursor",
                "accession": "4557759",
                "molecular_weight_kDa": "84",
                "context": "cancer_vs_control",
                "average_SC_cancer": "70.2",
                "average_SC_control": "11.0",
                "NSAF_ratio": "5.3",
                "p_value_t_test": "0.02501"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[70.2, 11.0, 5.3]"
        },
        {
            "subject": {
                "protein_name": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "molecular_weight_kDa": "31",
                "context": "cancer_vs_control",
                "average_SC_cancer": "29.8",
                "average_SC_control": "5.9",
                "NSAF_ratio": "5.7",
                "p_value_t_test": "0.02170"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[29.8, 5.9, 5.7]"
        },
        {
            "subject": {
                "protein_name": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "molecular_weight_kDa": "95",
                "context": "cancer_vs_control",
                "average_SC_cancer": "63.3",
                "average_SC_control": "9.3",
                "NSAF_ratio": "6.4",
                "p_value_t_test": "0.00031"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[63.3, 9.3, 6.4]"
        },
        {
            "subject": {
                "protein_name": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "molecular_weight_kDa": "39",
                "context": "cancer_vs_control",
                "average_SC_cancer": "7.3",
                "average_SC_control": "1.1",
                "NSAF_ratio": "6.5",
                "p_value_t_test": "0.00173"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[7.3, 1.1, 6.5]"
        },
        {
            "subject": {
                "protein_name": "Ceruloplasmin precursor",
                "accession": "4557485",
                "molecular_weight_kDa": "122",
                "context": "cancer_vs_control",
                "average_SC_cancer": "47.3",
                "average_SC_control": "5.6",
                "NSAF_ratio": "7.5",
                "p_value_t_test": "0.00114"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[47.3, 5.6, 7.5]"
        },
        {
            "subject": {
                "protein_name": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "molecular_weight_kDa": "193",
                "context": "cancer_vs_control",
                "average_SC_cancer": "32.1",
                "average_SC_control": "4.5",
                "NSAF_ratio": "7.7",
                "p_value_t_test": "0.01791"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[32.1, 4.5, 7.7]"
        },
        {
            "subject": {
                "protein_name": "Alpha-1B-glycoprotein precursor",
                "accession": "21071030",
                "molecular_weight_kDa": "54",
                "context": "cancer_vs_control",
                "average_SC_cancer": "10.9",
                "average_SC_control": "1.2",
                "NSAF_ratio": "8.3",
                "p_value_t_test": "0.00468"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[10.9, 1.2, 8.3]"
        },
        {
            "subject": {
                "protein_name": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                "accession": "31542984",
                "molecular_weight_kDa": "103",
                "context": "cancer_vs_control",
                "average_SC_cancer": "5.5",
                "average_SC_control": "0.2",
                "NSAF_ratio": "35.4",
                "p_value_t_test": "0.00484"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[5.5, 0.2, 35.4]"
        },
        {
            "subject": {
                "protein_name": "Apolipoprotein B-100 precursor",
                "accession": "105990532",
                "molecular_weight_kDa": "516",
                "context": "cancer_vs_control",
                "average_SC_cancer": "49.3",
                "average_SC_control": "1.0",
                "NSAF_ratio": "55.7",
                "p_value_t_test": "0.02595"
            },
            "measures": "[average_SC_cancer, average_SC_control, NSAF_ratio]",
            "outcomes": "[49.3, 1.0, 55.7]"
        }
    ],
    "PMC5589562_2": [
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-145-5p",
                "Accession no.": "MIMAT0000437"
            },
            "measures": "[Ratio]",
            "outcomes": "[8980.05]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-205-5p",
                "Accession no.": "MIMAT0000266"
            },
            "measures": "[Ratio]",
            "outcomes": "[23077.19]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-199a-5p",
                "Accession no.": "MIMAT0000231"
            },
            "measures": "[Ratio]",
            "outcomes": "[1563.68]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-200c-3p",
                "Accession no.": "MIMAT0000617"
            },
            "measures": "[Ratio]",
            "outcomes": "[5968.64]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-199b-5p",
                "Accession no.": "MIMAT0000263"
            },
            "measures": "[Ratio]",
            "outcomes": "[296.31]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-200b-3p",
                "Accession no.": "MIMAT0000318"
            },
            "measures": "[Ratio]",
            "outcomes": "[467.15]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-136-5p",
                "Accession no.": "MIMAT0000448"
            },
            "measures": "[Ratio]",
            "outcomes": "[228.24]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-429",
                "Accession no.": "MIMAT0001536"
            },
            "measures": "[Ratio]",
            "outcomes": "[171.07]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-137",
                "Accession no.": "MIMAT0000429"
            },
            "measures": "[Ratio]",
            "outcomes": "[227.70]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-196b-5p",
                "Accession no.": "MIMAT0001080"
            },
            "measures": "[Ratio]",
            "outcomes": "[116.42]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-139-5p",
                "Accession no.": "MIMAT0000250"
            },
            "measures": "[Ratio]",
            "outcomes": "[216.83]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-582-5p",
                "Accession no.": "MIMAT0003247"
            },
            "measures": "[Ratio]",
            "outcomes": "[99.53]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-127-3p",
                "Accession no.": "MIMAT0000446"
            },
            "measures": "[Ratio]",
            "outcomes": "[159.72]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-135b-5p",
                "Accession no.": "MIMAT0000758"
            },
            "measures": "[Ratio]",
            "outcomes": "[87.82]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-337-5p",
                "Accession no.": "MIMAT0004695"
            },
            "measures": "[Ratio]",
            "outcomes": "[148.57]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-182-5p",
                "Accession no.": "MIMAT0000259"
            },
            "measures": "[Ratio]",
            "outcomes": "[55.81]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-139-3p",
                "Accession no.": "MIMAT0004552"
            },
            "measures": "[Ratio]",
            "outcomes": "[146.36]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-96-5p",
                "Accession no.": "MIMAT0000095"
            },
            "measures": "[Ratio]",
            "outcomes": "[53.82]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-487b",
                "Accession no.": "MIMAT0003180"
            },
            "measures": "[Ratio]",
            "outcomes": "[118.72]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-200a-3p",
                "Accession no.": "MIMAT0000682"
            },
            "measures": "[Ratio]",
            "outcomes": "[44.88]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                "Accession no.": "MIMAT0000232"
            },
            "measures": "[Ratio]",
            "outcomes": "[107.49]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-4284",
                "Accession no.": "MIMAT0016915"
            },
            "measures": "[Ratio]",
            "outcomes": "[41.90]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-1233",
                "Accession no.": "MIMAT0005588"
            },
            "measures": "[Ratio]",
            "outcomes": "[66.04]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-345-5p",
                "Accession no.": "MIMAT0000772"
            },
            "measures": "[Ratio]",
            "outcomes": "[27.99]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-379-5p",
                "Accession no.": "MIMAT0000733"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.89]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-378g",
                "Accession no.": "MIMAT0018937"
            },
            "measures": "[Ratio]",
            "outcomes": "[25.01]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-660-5p",
                "Accession no.": "MIMAT0003338"
            },
            "measures": "[Ratio]",
            "outcomes": "[62.50]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-203",
                "Accession no.": "MIMAT0000264"
            },
            "measures": "[Ratio]",
            "outcomes": "[22.43]"
        },
        {
            "subject": {
                "context": "TAS cells",
                "comparison": "PC cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-335-5p",
                "Accession no.": "MIMAT0000765"
            },
            "measures": "[Ratio]",
            "outcomes": "[60.53]"
        },
        {
            "subject": {
                "context": "PC cells",
                "comparison": "TAS cells",
                "study": "this study",
                "miRNA probe ID": "hsa-miR-141-3p",
                "Accession no.": "MIMAT0000432"
            },
            "measures": "[Ratio]",
            "outcomes": "[21.69]"
        }
    ],
    "PMC4190529_6": [
        {
            "subject": {
                "Treatment": "gemcitabine",
                "Control": "5-fluorouracil",
                "Phase": "3",
                "Median Survival Therapy": "5.7 months",
                "Median Survival Control": "4.2 months",
                "One-Year Survival Therapy": "18%",
                "One-Year Survival Control": "2%",
                "Side Effects": "more favorable than 5-fluorouracil",
                "FDA Approval": "1996"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[5.7, 4.2, 18, 2]"
        },
        {
            "subject": {
                "Treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "Control": "gemcitabine",
                "Phase": "3",
                "Median Survival Therapy": "6.4 months",
                "Median Survival Control": "6 months",
                "One-Year Survival Therapy": "24%",
                "One-Year Survival Control": "19%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "2005"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[6.4, 6, 24, 19]"
        },
        {
            "subject": {
                "Treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "Control": "gemcitabine",
                "Phase": "3",
                "Median Survival Therapy": "8.5 months",
                "Median Survival Control": "6.7 months",
                "One-Year Survival Therapy": "35%",
                "One-Year Survival Control": "22%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "2013"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[8.5, 6.7, 35, 22]"
        },
        {
            "subject": {
                "Treatment": "FOLFIRINOX",
                "Control": "gemcitabine",
                "Phase": "2/3",
                "Median Survival Therapy": "11.1 months",
                "Median Survival Control": "6.8 months",
                "One-Year Survival Therapy": "48.4%",
                "One-Year Survival Control": "20.6%",
                "Side Effects": "less favorable than gemcitabine",
                "FDA Approval": "n/a",
                "Citation": "Oxaliplatin, irinotecan, fluorouracil and leucovorin"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[11.1, 6.8, 48.4, 20.6]"
        },
        {
            "subject": {
                "Treatment": "cell encapsulation + ifosfamide",
                "Control": "5-fluorouracil",
                "Phase": "2",
                "Median Survival Therapy": "10 months",
                "Median Survival Control": "5 months",
                "One-Year Survival Therapy": "36%",
                "One-Year Survival Control": "18%",
                "Side Effects": "more favorable than 5-fluorouracil or gemcitabine",
                "FDA Approval": "n/a",
                "Citation": "five patients experienced Grade 3 or Grade 4 NCI toxicities with a higher dose of 2 g/m2 and a median survival of 9.5 months"
            },
            "measures": "[Median Survival Therapy, Median Survival Control, One-Year Survival Therapy, One-Year Survival Control]",
            "outcomes": "[10, 5, 36, 18]"
        }
    ],
    "PMC5675623_3": [
        {
            "subject": {
                "variable": "ECOG performance status",
                "contrast": "> 0 vs. 0",
                "hazard ratio": "1.47 (0.90, 2.41)",
                "p value": "0.12",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.47 (0.90, 2.41), 0.12]"
        },
        {
            "subject": {
                "variable": "Liver metastases",
                "contrast": "Yes vs. No",
                "hazard ratio": "1.72 (1.01, 2.91)",
                "p value": "0.045",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.72 (1.01, 2.91), 0.045]"
        },
        {
            "subject": {
                "variable": "No. of metastatic sites",
                "contrast": ">2 vs. <= 2",
                "hazard ratio": "1.33 (0.9, 2.25)",
                "p value": "0.28",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.33 (0.9, 2.25), 0.28]"
        },
        {
            "subject": {
                "variable": "Prior radiation therapy",
                "contrast": "Yes vs. No",
                "hazard ratio": "1.58 (0.95, 2.61)",
                "p value": "0.077",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.58 (0.95, 2.61), 0.077]"
        },
        {
            "subject": {
                "variable": "Prior FOLFIRINOX",
                "contrast": "Yes vs. No",
                "hazard ratio": "1.73 (1.01, 2.98)",
                "p value": "0.046",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment",
                "citation": "FOLFIRINOX"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.73 (1.01, 2.98), 0.046]"
        },
        {
            "subject": {
                "variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                "contrast": "Yes vs. No",
                "hazard ratio": "1.08 (0.58, 2.01)",
                "p value": "0.80",
                "analysis type": "multivariate Cox proportional hazards regression",
                "endpoint": "overall survival (OS)",
                "phase": "first phase I treatment"
            },
            "measures": "[hazard ratio, p value]",
            "outcomes": "[1.08 (0.58, 2.01), 0.80]"
        }
    ],
    "PMC4742219_3": [
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Age",
                "HR": "1.00",
                "95% CI": "(0.98, 1.02)",
                "P_value": "0.874"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.00, (0.98, 1.02), 0.874]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Gender (female vs. male)",
                "HR": "0.89",
                "95% CI": "(0.60, 1.31)",
                "P_value": "0.544"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[0.89, (0.60, 1.31), 0.544]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Tumor size",
                "HR": "1.13",
                "95% CI": "(0.97, 1.33)",
                "P_value": "0.127"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.13, (0.97, 1.33), 0.127]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Tumor grade",
                "comparison": "Grade II vs. I",
                "HR": "1.00",
                "95% CI": "(0.69, 1.45)",
                "P_value": "0.991"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.00, (0.69, 1.45), 0.991]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Tumor grade",
                "comparison": "Grade III vs. I",
                "HR": "0.93",
                "95% CI": "(0.27, 3.17)",
                "P_value": "0.906"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[0.93, (0.27, 3.17), 0.906]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Lymph Nodes (yes vs. no)",
                "HR": "1.39",
                "95% CI": "(0.81, 2.38)",
                "P_value": "0.229"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.39, (0.81, 2.38), 0.229]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Margin (positive vs. negative)",
                "HR": "1.54",
                "95% CI": "(1.06, 2.25)",
                "P_value": "0.025"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.54, (1.06, 2.25), 0.025]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Vascular invasion (yes vs. no)",
                "HR": "0.99",
                "95% CI": "(0.69, 1.42)",
                "P_value": "0.967"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[0.99, (0.69, 1.42), 0.967]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Perineural invasion (yes vs. no)",
                "HR": "2.19",
                "95% CI": "(0.87, 5.49)",
                "P_value": "0.097"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[2.19, (0.87, 5.49), 0.097]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Time from surgery to first recurrence",
                "HR": "1.00",
                "95% CI": "(0.98, 1.02)",
                "P_value": "0.883"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.00, (0.98, 1.02), 0.883]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Lung + Other vs. Lung",
                "HR": "1.25",
                "95% CI": "(0.63, 2.48)",
                "P_value": "0.516"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.25, (0.63, 2.48), 0.516]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Liver + Other vs. Lung",
                "HR": "1.91",
                "95% CI": "(1.10, 3.31)",
                "P_value": "0.022"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[1.91, (1.10, 3.31), 0.022]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Peritoneal vs. Lung",
                "HR": "6.32",
                "95% CI": "(3.12, 12.79)",
                "P_value": "< .001"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[6.32, (3.12, 12.79), < .001]"
        },
        {
            "subject": {
                "analysis_type": "multivariable analysis",
                "endpoint": "time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Local vs. Lung",
                "HR": "2.09",
                "95% CI": "(1.10, 4.00)",
                "P_value": "0.025"
            },
            "measures": "[HR, 95% CI, P_value]",
            "outcomes": "[2.09, (1.10, 4.00), 0.025]"
        }
    ],
    "PMC4941379_3": [
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG\u2212/CagA\u2212",
                "Sample size": "4,555",
                "Cases": "5",
                "Crude incidence rate (per 100": "000 person-years), 10.42",
                "HR1 (95% CI)": "Ref",
                "HR2 (95% CI)": "Ref"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[10.42]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA\u2212",
                "Sample size": "1,984",
                "Cases": "2",
                "Crude incidence rate (per 100": "000 person-years), 9.54",
                "HR1 (95% CI)": "0.79 (0.15\u20134.08)",
                "HR2 (95% CI)": "Ref"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[9.54]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA+",
                "Sample size": "2,295",
                "Cases": "14",
                "Crude incidence rate (per 100": "000 person-years), 58.13",
                "HR1 (95% CI)": "5.05 (1.81\u201314.09)",
                "HR2 (95% CI)": "Ref"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[58.13]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG\u2212/CagA\u2212",
                "Sample size": "205",
                "Cases": "0",
                "Crude incidence rate (per 100": "000 person-years), 0",
                "HR1 (95% CI)": "3.45 (1.38\u20138.64)",
                "HR2 (95% CI)": "Not estimable"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA\u2212",
                "Sample size": "143",
                "Cases": "1",
                "Crude incidence rate (per 100": "000 person-years), 64.61",
                "HR1 (95% CI)": "5.50 (0.63\u201347.57)",
                "HR2 (95% CI)": "Not estimable"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[64.61]"
        },
        {
            "subject": {
                "Chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA+",
                "Sample size": "315",
                "Cases": "5",
                "Crude incidence rate (per 100": "000 person-years), 151.20",
                "HR1 (95% CI)": "12.51 (3.57\u201343.22)",
                "HR2 (95% CI)": "Not estimable"
            },
            "measures": "[Crude incidence rate]",
            "outcomes": "[151.20]"
        }
    ],
    "PMC3987090_4": [
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": "\u22641",
                "n_percentage": "14 (5.6)",
                "median_OS_months": "12.8 (9.4\u201316.2)",
                "hazard_ratio": "1",
                "95%_CI": "0.86\u20133.29",
                "p_value": "0.13"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 0.86\u20133.29, 0.13]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": "\u22641",
                "n_percentage": "14 (5.6)",
                "median_OS_months": "12.8 (9.4\u201316.2)",
                "hazard_ratio": "1",
                "95%_CI": "0.69\u20132.71",
                "p_value": "0.37"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 0.69\u20132.71, 0.37]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": ">1",
                "n_percentage": "238 (94.4)",
                "median_OS_months": "11.7 (10.4\u201313.0)",
                "hazard_ratio": "1.68"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.68]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": ">1",
                "n_percentage": "238 (94.4)",
                "median_OS_months": "11.7 (10.4\u201313.0)",
                "hazard_ratio": "1.37"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.37]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": "\u22642",
                "n_percentage": "83 (32.9)",
                "median_OS_months": "14.8 (11.5\u201318.2)",
                "hazard_ratio": "1",
                "95%_CI": "1.13\u20132.05",
                "p_value": "0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.13\u20132.05, 0.01]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": "\u22642",
                "n_percentage": "83 (32.9)",
                "median_OS_months": "14.8 (11.5\u201318.2)",
                "hazard_ratio": "1",
                "95%_CI": "0.88\u20131.66",
                "p_value": "0.24"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 0.88\u20131.66, 0.24]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": ">2",
                "n_percentage": "169 (67.1)",
                "median_OS_months": "10.7 (9.3\u201312.1)",
                "hazard_ratio": "1.52"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.52]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": ">2",
                "n_percentage": "169 (67.1)",
                "median_OS_months": "10.7 (9.3\u201312.1)",
                "hazard_ratio": "1.21"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.21]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": "\u22643",
                "n_percentage": "158 (62.7)",
                "median_OS_months": "13.4 (11.1\u201315.7)",
                "hazard_ratio": "1",
                "95%_CI": "1.26\u20132.23",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.26\u20132.23, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": "\u22643",
                "n_percentage": "158 (62.7)",
                "median_OS_months": "13.4 (11.1\u201315.7)",
                "hazard_ratio": "1",
                "95%_CI": "1.18\u20132.11",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.18\u20132.11, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": ">3",
                "n_percentage": "94 (37.3)",
                "median_OS_months": "8.6 (6.2\u201311.0)",
                "hazard_ratio": "1.68"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.68]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": ">3",
                "n_percentage": "94 (37.3)",
                "median_OS_months": "8.6 (6.2\u201311.0)",
                "hazard_ratio": "1.57"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.57]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": "\u22644",
                "n_percentage": "194 (77.0)",
                "median_OS_months": "13.3 (11.4\u201315.2)",
                "hazard_ratio": "1",
                "95%_CI": "1.44\u20132.78",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.44\u20132.78, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": "\u22644",
                "n_percentage": "194 (77.0)",
                "median_OS_months": "13.3 (11.4\u201315.2)",
                "hazard_ratio": "1",
                "95%_CI": "1.36\u20132.67",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.36\u20132.67, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": ">4",
                "n_percentage": "58 (23.0)",
                "median_OS_months": "7.3 (5.6\u20139.0)",
                "hazard_ratio": "2.00"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[2.00]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": ">4",
                "n_percentage": "58 (23.0)",
                "median_OS_months": "7.3 (5.6\u20139.0)",
                "hazard_ratio": "1.91"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[1.91]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": "\u22645",
                "n_percentage": "212 (84.1)",
                "median_OS_months": "12.8 (10.7\u201314.9)",
                "hazard_ratio": "1",
                "95%_CI": "1.50\u20133.15",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.50\u20133.15, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": "\u22645",
                "n_percentage": "212 (84.1)",
                "median_OS_months": "12.8 (10.7\u201314.9)",
                "hazard_ratio": "1",
                "95%_CI": "1.49\u20133.15",
                "p_value": "<0.01"
            },
            "measures": "[hazard_ratio, 95%_CI, p_value]",
            "outcomes": "[1, 1.49\u20133.15, <0.01]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "NLR_threshold": ">5",
                "n_percentage": "40 (15.9)",
                "median_OS_months": "6.0 (2.8\u20139.2)",
                "hazard_ratio": "2.17"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[2.17]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "NLR_threshold": ">5",
                "n_percentage": "40 (15.9)",
                "median_OS_months": "6.0 (2.8\u20139.2)",
                "hazard_ratio": "2.16"
            },
            "measures": "[hazard_ratio]",
            "outcomes": "[2.16]"
        }
    ],
    "PMC3987090_5": [
        {
            "subject": {
                "study": "An X et al.",
                "year": "2010",
                "n": "89",
                "number of patients with NLR >5 (%)": "16 (17.9)",
                "overall survival (NLR >5 vs. \u22645) (months)": "2.4 versus 7.7",
                "hazard ratio (NLR \u22645 was set at 1)": "HR = 4.49, P = 0.013",
                "context": "published studies reporting the association between NLR and the prognosis of APC patients receiving chemotherapy"
            },
            "measures": "[n, number of patients with NLR >5 (%)]",
            "outcomes": "[overall survival (NLR >5 vs. \u22645) (months), hazard ratio (NLR \u22645 was set at 1)]"
        },
        {
            "subject": {
                "study": "Wang DS et al.",
                "year": "2012",
                "n": "86",
                "number of patients with NLR >5 (%)": "12 (13.9)",
                "overall survival (NLR >5 vs. \u22645) (months)": "5.8 versus 10.2",
                "hazard ratio (NLR \u22645 was set at 1)": "NA",
                "context": "published studies reporting the association between NLR and the prognosis of APC patients receiving chemotherapy"
            },
            "measures": "[n, number of patients with NLR >5 (%)]",
            "outcomes": "[overall survival (NLR >5 vs. \u22645) (months)]"
        },
        {
            "subject": {
                "study": "Stotz M et al.",
                "year": "2013",
                "n": "261",
                "number of patients with NLR >5 (%)": "79 (30.3)",
                "overall survival (NLR >5 vs. \u22645) (months)": "NA",
                "hazard ratio (NLR \u22645 was set at 1)": "HR = 2.53, P < 0.01",
                "context": "published studies reporting the association between NLR and the prognosis of APC patients receiving chemotherapy",
                "footnote": "This study (n = 261) pooled the data from patients who received chemotherapy (n = 179) and no chemotherapy (n = 82)"
            },
            "measures": "[n, number of patients with NLR >5 (%)]",
            "outcomes": "[hazard ratio (NLR \u22645 was set at 1)]"
        },
        {
            "subject": {
                "study": "Our study",
                "year": "2013",
                "n": "253",
                "number of patients with NLR >5 (%)": "40 (15.8)",
                "overall survival (NLR >5 vs. \u22645) (months)": "6.0 versus 12.8",
                "hazard ratio (NLR \u22645 was set at 1)": "HR = 1.95, P < 0.01",
                "context": "published studies reporting the association between NLR and the prognosis of APC patients receiving chemotherapy"
            },
            "measures": "[n, number of patients with NLR >5 (%)]",
            "outcomes": "[overall survival (NLR >5 vs. \u22645) (months), hazard ratio (NLR \u22645 was set at 1)]"
        }
    ],
    "PMC3544459_4": [
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "no",
                "median_survival_time_months": "33.2 \u00b1 1.8",
                "p_value_log_rank": "0.049",
                "univariate_hr_95ci": "1.0",
                "univariate_p": "0.050",
                "multivariate_hr_95ci": "1.0",
                "multivariate_p": "0.036"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[33.2 \u00b1 1.8, 1.0, 1.0]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes_status": "yes",
                "median_survival_time_months": "24.6 \u00b1 2.5",
                "p_value_log_rank": "0.049",
                "univariate_hr_95ci": "1.27 (1.00\u20131.60)",
                "univariate_p": "0.050",
                "multivariate_hr_95ci": "1.29 (1.02\u20131.64)",
                "multivariate_p": "0.036"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[24.6 \u00b1 2.5, 1.27 (1.00\u20131.60), 1.29 (1.02\u20131.64)]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural_invasion_status": "no",
                "median_survival_time_months": "51.7 \u00b1 31.1",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.0",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.0",
                "multivariate_p": "0.019"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[51.7 \u00b1 31.1, 1.0, 1.0]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural_invasion_status": "yes",
                "median_survival_time_months": "29.4 \u00b1 1.64",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "2.01 (1.38\u20132.93)",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.60 (1.08\u20132.36)",
                "multivariate_p": "0.019"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[29.4 \u00b1 1.64, 2.01 (1.38\u20132.93), 1.60 (1.08\u20132.36)]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin_status": "negative",
                "median_survival_time_months": "33.6 \u00b1 1.7",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.0",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.0",
                "multivariate_p": "0.003"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[33.6 \u00b1 1.7, 1.0, 1.0]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin_status": "positive",
                "median_survival_time_months": "24.8 \u00b1 2.6",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.62 (1.27\u20132.08)",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.47 (1.14\u20131.90)",
                "multivariate_p": "0.003"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[24.8 \u00b1 2.6, 1.62 (1.27\u20132.08), 1.47 (1.14\u20131.90)]"
        },
        {
            "subject": {
                "condition": "node status",
                "node_status": "negative",
                "median_survival_time_months": "38.6 \u00b1 5.3",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.0",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.0",
                "multivariate_p": "0.002"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[38.6 \u00b1 5.3, 1.0, 1.0]"
        },
        {
            "subject": {
                "condition": "node status",
                "node_status": "positive",
                "median_survival_time_months": "27.5 \u00b1 1.3",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.70 (1.35\u20132.15)",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.45 (1.14\u20131.83)",
                "multivariate_p": "0.002"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[27.5 \u00b1 1.3, 1.70 (1.35\u20132.15), 1.45 (1.14\u20131.83)]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "well\u2013moderate",
                "median_survival_time_months": "35.9 \u00b1 2.68",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.0",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.0",
                "multivariate_p": "<0.001"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[35.9 \u00b1 2.68, 1.0, 1.0]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation_status": "poor",
                "median_survival_time_months": "26.0 \u00b1 1.77",
                "p_value_log_rank": "<0.001",
                "univariate_hr_95ci": "1.63 (1.32\u20132.02)",
                "univariate_p": "<0.001",
                "multivariate_hr_95ci": "1.63 (1.32\u20132.02)",
                "multivariate_p": "<0.001"
            },
            "measures": "[median_survival_time_months, univariate_hr_95ci, multivariate_hr_95ci]",
            "outcomes": "[26.0 \u00b1 1.77, 1.63 (1.32\u20132.02), 1.63 (1.32\u20132.02)]"
        }
    ],
    "PMC3497287_3": [
        {
            "subject": {
                "Inherited Syndrome": "Lynch Syndrome",
                "Mutated Gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2",
                "Context": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Inherited Syndrome": "Peutz-Jeghers Syndrome",
                "Mutated Gene": "STK11/LKB1",
                "Context": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Inherited Syndrome": "Hereditary Breast Cancer",
                "Mutated Gene": "BRCA1/BRCA2",
                "Context": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "Inherited Syndrome": "Familial Atypical Multiple Mole Melanoma",
                "Mutated Gene": "CDKN2A mutation",
                "Context": "Inherited pancreatic cancer syndromes"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ],
    "PMC4728116_3": [
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "group": "no",
                "cases_n": "312",
                "cases_percentage": "96.6",
                "controls_n": "320",
                "controls_percentage": "99.1",
                "crude_or": "1.00 (reference)",
                "adjusted_or1": "1.00 (reference)",
                "adjusted_or2": "1.00 (reference)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "group": "yes",
                "cases_n": "11",
                "cases_percentage": "3.4",
                "controls_n": "3",
                "controls_percentage": "0.9",
                "crude_or": "3.67 (1.02\u201313.14)",
                "adjusted_or1": "4.04 (1.08\u201315.07)",
                "adjusted_or2": "1.23 (1.11\u20133.70)"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[3.67 (1.02\u201313.14), 4.04 (1.08\u201315.07), 1.23 (1.11\u20133.70)]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "<24.0",
                "cases_n": "197",
                "cases_percentage": "61.0",
                "controls_n": "230",
                "controls_percentage": "71.2",
                "crude_or": "1.00 (reference)",
                "adjusted_or1": "1.00 (reference)",
                "adjusted_or2": "1.00 (reference)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "group": "\u226524.0",
                "cases_n": "126",
                "cases_percentage": "39.0",
                "controls_n": "93",
                "controls_percentage": "28.8",
                "crude_or": "1.67 (1.18\u20132.38)",
                "adjusted_or1": "1.78 (1.23\u20132.58)",
                "adjusted_or2": "1.77 (1.22\u20132.57)"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.67 (1.18\u20132.38), 1.78 (1.23\u20132.58), 1.77 (1.22\u20132.57)]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "group": "no",
                "cases_n": "174",
                "cases_percentage": "78.0",
                "controls_n": "255",
                "controls_percentage": "90.7",
                "crude_or": "1.00 (reference)",
                "adjusted_or1": "1.00 (reference)",
                "adjusted_or2": "1.00 (reference)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "group": "yes",
                "cases_n": "49",
                "cases_percentage": "22.0",
                "controls_n": "26",
                "controls_percentage": "9.3",
                "crude_or": "2.69 (1.51\u20134.77)",
                "adjusted_or1": "2.60 (1.41\u20134.79)",
                "adjusted_or2": "2.96 (1.48\u20135.92)"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[2.69 (1.51\u20134.77), 2.60 (1.41\u20134.79), 2.96 (1.48\u20135.92)]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "group": "no",
                "cases_n": "272",
                "cases_percentage": "94.1",
                "controls_n": "195",
                "controls_percentage": "96.7",
                "crude_or": "1.00 (reference)",
                "adjusted_or1": "1.00 (reference)",
                "adjusted_or2": "1.00 (reference)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "group": "yes",
                "cases_n": "17",
                "cases_percentage": "5.9",
                "controls_n": "10",
                "controls_percentage": "3.3",
                "crude_or": "1.89 (0.84\u20134.24)",
                "adjusted_or1": "1.91 (0.83\u20134.38)",
                "adjusted_or2": "1.35 (0.50\u20133.68)"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[1.89 (0.84\u20134.24), 1.91 (0.83\u20134.38), 1.35 (0.50\u20133.68)]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "group": "no",
                "cases_n": "274",
                "cases_percentage": "95.1",
                "controls_n": "300",
                "controls_percentage": "98.4",
                "crude_or": "1.00 (reference)",
                "adjusted_or1": "1.00 (reference)",
                "adjusted_or2": "1.00 (reference)"
            },
            "measures": "[]",
            "outcomes": "[]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "group": "yes",
                "cases_n": "14",
                "cases_percentage": "4.9",
                "controls_n": "5",
                "controls_percentage": "1.6",
                "crude_or": "2.80 (1.01\u20137.77)",
                "adjusted_or1": "2.58 (0.89\u20137.44)",
                "adjusted_or2": "2.68 (0.65\u201311.07)"
            },
            "measures": "[crude_or, adjusted_or1, adjusted_or2]",
            "outcomes": "[2.80 (1.01\u20137.77), 2.58 (0.89\u20137.44), 2.68 (0.65\u201311.07)]"
        }
    ],
    "PMC4741511_2": [
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "31",
                "patients percentage": "44%"
            },
            "measures": "[PFS (months)]",
            "outcomes": "[7.6]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "31",
                "patients percentage": "44%"
            },
            "measures": "[OS (months)]",
            "outcomes": "[12.7]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "6",
                "patients percentage": "8%"
            },
            "measures": "[PFS (months)]",
            "outcomes": "[2.8]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "6",
                "patients percentage": "8%"
            },
            "measures": "[OS (months)]",
            "outcomes": "[5.9]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "No Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "27",
                "patients percentage": "38%"
            },
            "measures": "[PFS (months)]",
            "outcomes": "[3.3]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "No Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "27",
                "patients percentage": "38%"
            },
            "measures": "[OS (months)]",
            "outcomes": "[8.6]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "No Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "7",
                "patients percentage": "10%"
            },
            "measures": "[PFS (months)]",
            "outcomes": "[2.2]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "population subgroup": "No Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "7",
                "patients percentage": "10%"
            },
            "measures": "[OS (months)]",
            "outcomes": "[5.2]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "comparison": "Sorafenib vs No Sorafenib",
                "LDH level": "\u2264 UNR"
            },
            "measures": "[p-value (PFS)]",
            "outcomes": "[0.05]"
        },
        {
            "subject": {
                "study": "MAPS",
                "phase": "II",
                "comparison": "Sorafenib vs No Sorafenib",
                "LDH level": "\u2264 UNR"
            },
            "measures": "[p-value (OS)]",
            "outcomes": "[0.0012]"
        }
    ],
    "PMC5522086_3": [
        {
            "subject": {
                "upstream_regulator": "TP53",
                "log_ratio": "None",
                "activation_z_score": "\u22122.353",
                "p_value_of_overlap": "3.34\u00d710^\u221232",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.353, 3.34\u00d710^\u221232]"
        },
        {
            "subject": {
                "upstream_regulator": "NUPR1",
                "log_ratio": "\u22122.52",
                "activation_z_score": "\u22123.977",
                "p_value_of_overlap": "4.62\u00d710^\u221213",
                "context": "inhibition"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.52, \u22123.977, 4.62\u00d710^\u221213]"
        },
        {
            "subject": {
                "upstream_regulator": "NKX2-3",
                "log_ratio": "None",
                "activation_z_score": "\u22123.455",
                "p_value_of_overlap": "5.88\u00d710^\u221212",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22123.455, 5.88\u00d710^\u221212]"
        },
        {
            "subject": {
                "upstream_regulator": "HNF1A",
                "log_ratio": "None",
                "activation_z_score": "\u22122.359",
                "p_value_of_overlap": "8.82\u00d710^\u221212",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.359, 8.82\u00d710^\u221212]"
        },
        {
            "subject": {
                "upstream_regulator": "CDKN2A",
                "log_ratio": "1.737",
                "activation_z_score": "\u22123.219",
                "p_value_of_overlap": "1.34\u00d710^\u221211",
                "context": "inhibition"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[1.737, \u22123.219, 1.34\u00d710^\u221211]"
        },
        {
            "subject": {
                "upstream_regulator": "estrogen receptor",
                "log_ratio": "None",
                "activation_z_score": "\u22122.299",
                "p_value_of_overlap": "9.57\u00d710^\u221210",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.299, 9.57\u00d710^\u221210]"
        },
        {
            "subject": {
                "upstream_regulator": "RB1",
                "log_ratio": "None",
                "activation_z_score": "\u22124.286",
                "p_value_of_overlap": "3.74\u00d710^\u221208",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22124.286, 3.74\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "TCF3",
                "log_ratio": "None",
                "activation_z_score": "\u22123.116",
                "p_value_of_overlap": "4.32\u00d710^\u221208",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22123.116, 4.32\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "TRIM24",
                "log_ratio": "None",
                "activation_z_score": "\u22123.714",
                "p_value_of_overlap": "6.26\u00d710^\u221207",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22123.714, 6.26\u00d710^\u221207]"
        },
        {
            "subject": {
                "upstream_regulator": "BCL6",
                "log_ratio": "None",
                "activation_z_score": "\u22122.313",
                "p_value_of_overlap": "1.60\u00d710^\u221206",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.313, 1.60\u00d710^\u221206]"
        },
        {
            "subject": {
                "upstream_regulator": "NR5A2",
                "log_ratio": "\u22122.876",
                "activation_z_score": "\u22122.7",
                "p_value_of_overlap": "7.26\u00d710^\u221206",
                "context": "inhibition"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.876, \u22122.7, 7.26\u00d710^\u221206]"
        },
        {
            "subject": {
                "upstream_regulator": "SATB1",
                "log_ratio": "\u22120.814",
                "activation_z_score": "\u22122.003",
                "p_value_of_overlap": "1.09\u00d710^\u221205",
                "context": "inhibition"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22120.814, \u22122.003, 1.09\u00d710^\u221205]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF4",
                "log_ratio": "2.115",
                "activation_z_score": "\u22122.41",
                "p_value_of_overlap": "4.24\u00d710^\u221205",
                "context": "inhibition"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.115, \u22122.41, 4.24\u00d710^\u221205]"
        },
        {
            "subject": {
                "upstream_regulator": "RBL1",
                "log_ratio": "None",
                "activation_z_score": "\u22123.124",
                "p_value_of_overlap": "1.72\u00d710^\u221204",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22123.124, 1.72\u00d710^\u221204]"
        },
        {
            "subject": {
                "upstream_regulator": "SPDEF",
                "log_ratio": "None",
                "activation_z_score": "\u22122.887",
                "p_value_of_overlap": "2.39\u00d710^\u221204",
                "context": "inhibition"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[\u22122.887, 2.39\u00d710^\u221204]"
        },
        {
            "subject": {
                "upstream_regulator": "STAT3",
                "log_ratio": "None",
                "activation_z_score": "2.924",
                "p_value_of_overlap": "5.78\u00d710^\u221219",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.924, 5.78\u00d710^\u221219]"
        },
        {
            "subject": {
                "upstream_regulator": "CTNNB1",
                "log_ratio": "None",
                "activation_z_score": "3.359",
                "p_value_of_overlap": "1.99\u00d710^\u221215",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.359, 1.99\u00d710^\u221215]"
        },
        {
            "subject": {
                "upstream_regulator": "SP1",
                "log_ratio": "None",
                "activation_z_score": "2.06",
                "p_value_of_overlap": "4.79\u00d710^\u221213",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.06, 4.79\u00d710^\u221213]"
        },
        {
            "subject": {
                "upstream_regulator": "CEBPB",
                "log_ratio": "None",
                "activation_z_score": "2.866",
                "p_value_of_overlap": "2.62\u00d710^\u221212",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.866, 2.62\u00d710^\u221212]"
        },
        {
            "subject": {
                "upstream_regulator": "NFkB (complex)",
                "log_ratio": "None",
                "activation_z_score": "6.314",
                "p_value_of_overlap": "1.43\u00d710^\u221211",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[6.314, 1.43\u00d710^\u221211]"
        },
        {
            "subject": {
                "upstream_regulator": "TBX2",
                "log_ratio": "None",
                "activation_z_score": "4.99",
                "p_value_of_overlap": "1.62\u00d710^\u221211",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[4.99, 1.62\u00d710^\u221211]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF1",
                "log_ratio": "None",
                "activation_z_score": "3.759",
                "p_value_of_overlap": "2.76\u00d710^\u221211",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.759, 2.76\u00d710^\u221211]"
        },
        {
            "subject": {
                "upstream_regulator": "IRF7",
                "log_ratio": "1.504",
                "activation_z_score": "5.591",
                "p_value_of_overlap": "2.88\u00d710^\u221210",
                "context": "activation"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[1.504, 5.591, 2.88\u00d710^\u221210]"
        },
        {
            "subject": {
                "upstream_regulator": "FOXM1",
                "log_ratio": "2.152",
                "activation_z_score": "4.395",
                "p_value_of_overlap": "5.12\u00d710^\u221210",
                "context": "activation"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.152, 4.395, 5.12\u00d710^\u221210]"
        },
        {
            "subject": {
                "upstream_regulator": "STAT1",
                "log_ratio": "None",
                "activation_z_score": "4.576",
                "p_value_of_overlap": "2.05\u00d710^\u221208",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[4.576, 2.05\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "ETS1",
                "log_ratio": "0.863",
                "activation_z_score": "2.575",
                "p_value_of_overlap": "5.06\u00d710^\u221208",
                "context": "activation"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[0.863, 2.575, 5.06\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "JUN",
                "log_ratio": "None",
                "activation_z_score": "2.045",
                "p_value_of_overlap": "5.57\u00d710^\u221208",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.045, 5.57\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "FOXO1",
                "log_ratio": "None",
                "activation_z_score": "3.242",
                "p_value_of_overlap": "9.35\u00d710^\u221208",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[3.242, 9.35\u00d710^\u221208]"
        },
        {
            "subject": {
                "upstream_regulator": "E2F3",
                "log_ratio": "1.137",
                "activation_z_score": "2.394",
                "p_value_of_overlap": "1.16\u00d710^\u221206",
                "context": "activation"
            },
            "measures": "[log_ratio, activation_z_score, p_value_of_overlap]",
            "outcomes": "[1.137, 2.394, 1.16\u00d710^\u221206]"
        },
        {
            "subject": {
                "upstream_regulator": "MBD2",
                "log_ratio": "None",
                "activation_z_score": "2.549",
                "p_value_of_overlap": "5.41\u00d710^\u221206",
                "context": "activation"
            },
            "measures": "[activation_z_score, p_value_of_overlap]",
            "outcomes": "[2.549, 5.41\u00d710^\u221206]"
        }
    ],
    "PMC3428781_1": [
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "Vitamin A lipid droplets",
                "status": "present"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "Vitamin A lipid droplets",
                "status": "absent"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "\u03b1 Smooth muscle actin",
                "status": "absent"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "\u03b1 Smooth muscle actin",
                "status": "present"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "proliferation",
                "status": "limited"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "proliferation",
                "status": "increased"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "migration",
                "status": "limited"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "migration",
                "status": "increased"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "extracellular matrix production",
                "status": "limited"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "extracellular matrix production",
                "status": "increased"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "status": "complement of MMPs and TIMPs to maintain normal ECM turnover"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)",
                "status": "change in types of MMPs and TIMPs to facilitate ECM deposition"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "production of cytokines",
                "status": "limited"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "production of cytokines",
                "status": "increased",
                "specific cytokines": "PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "capacity for phagocytosis",
                "status": "absent"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "capacity for phagocytosis",
                "status": "present"
            }
        },
        {
            "subject": {
                "phenotype": "quiescent PSCs",
                "feature": "proteomic analyses",
                "status": "basal protein expression"
            }
        },
        {
            "subject": {
                "phenotype": "activated PSCs",
                "feature": "proteomic analyses",
                "status": "differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion"
            }
        }
    ],
    "PMC4941331_3": [
        {
            "subject": {
                "source": "Table 3",
                "association": "nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tumor tissue sample": "Cytoplasmic CDH1 Low",
                "nuclear HDAC3 expression": "Low",
                "count": "34"
            },
            "measures": "[count]",
            "outcomes": "[34]"
        },
        {
            "subject": {
                "source": "Table 3",
                "association": "nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tumor tissue sample": "Cytoplasmic CDH1 Low",
                "nuclear HDAC3 expression": "High",
                "count": "22"
            },
            "measures": "[count]",
            "outcomes": "[22]"
        },
        {
            "subject": {
                "source": "Table 3",
                "association": "nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tumor tissue sample": "Cytoplasmic CDH1 High",
                "nuclear HDAC3 expression": "Low",
                "count": "4"
            },
            "measures": "[count]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "source": "Table 3",
                "association": "nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tumor tissue sample": "Cytoplasmic CDH1 High",
                "nuclear HDAC3 expression": "High",
                "count": "24"
            },
            "measures": "[count]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "source": "Table 3",
                "association": "nuclear HDAC3 and cytoplasmic CDH1 expression",
                "correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[0.440, < 0.001]"
        },
        {
            "subject": {
                "source": "Citation",
                "inverse correlation": "low membrane expression of CDH1 and high nuclear HDAC3 expression",
                "Spearman correlation coefficient": "\u22120.348",
                "P-value": "0.001"
            },
            "measures": "[Spearman correlation coefficient, P-value]",
            "outcomes": "[\u22120.348, 0.001]"
        },
        {
            "subject": {
                "source": "Citation",
                "positive correlation": "high cytoplasmic CDH1 expression and high nuclear HDAC3 expression",
                "Spearman correlation coefficient": "0.440",
                "P-value": "< 0.001"
            },
            "measures": "[Spearman correlation coefficient, P-value]",
            "outcomes": "[0.440, < 0.001]"
        },
        {
            "subject": {
                "source": "Citation",
                "no correlation": "cytoplasmic HDAC3 expression and CDH1 expression location",
                "P-value": "> 0.05"
            },
            "measures": "[P-value]",
            "outcomes": "[> 0.05]"
        }
    ],
    "PMC6062623_3": [
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.1"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.76]",
                "[p-value]",
                "[0.002]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.15"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.15]",
                "[p-value]",
                "[0.008]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.2"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.25]",
                "[p-value]",
                "[0.006]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Right",
                "density": "0.25"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.08]",
                "[p-value]",
                "[0.009]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.1"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-1.04]",
                "[p-value]",
                "[0.32]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.15"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-2.58]",
                "[p-value]",
                "[0.022]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.2"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.36]",
                "[p-value]",
                "[0.005]"
            ]
        },
        {
            "subject": {
                "hypothesis": "State transition",
                "graph metric": "Local efficiency",
                "hemisphere": "Left",
                "density": "0.25"
            },
            "measures": "[t-statistic]",
            "outcomes": [
                "[-3.04]",
                "[p-value]",
                "[0.01]"
            ]
        }
    ],
    "PMC5464866_2": [
        {
            "subject": {
                "context": "FXR expression in pancreatic cancer",
                "comparison": "cancerous tissues vs adjacent tissues",
                "source": "Table 2",
                "method": "immunohistochemistry",
                "group": "cancerous tissues",
                "sample size": "88",
                "positive FXR expression": "54 (61.4%)",
                "negative FXR expression": "34 (38.6%)",
                "statistical significance": "P < 0.05"
            },
            "measures": "[positive FXR expression, negative FXR expression]",
            "outcomes": "[61.4%, 38.6%]"
        },
        {
            "subject": {
                "context": "FXR expression in pancreatic cancer",
                "comparison": "cancerous tissues vs adjacent tissues",
                "source": "Table 2",
                "method": "immunohistochemistry",
                "group": "adjacent tissues",
                "sample size": "88",
                "positive FXR expression": "27 (30.7%)",
                "negative FXR expression": "61 (69.3%)",
                "statistical significance": "P < 0.05"
            },
            "measures": "[positive FXR expression, negative FXR expression]",
            "outcomes": "[30.7%, 69.3%]"
        },
        {
            "subject": {
                "context": "FXR expression in pancreatic cancer",
                "comparison": "cancerous tissues vs adjacent tissues",
                "source": "Table 2",
                "method": "immunohistochemistry",
                "statistical significance": "P < 0.05",
                "finding": "significant difference in FXR expression between cancerous and paired normal tissues"
            },
            "measures": "[]",
            "outcomes": ""
        },
        {
            "subject": {
                "context": "FXR expression in pancreatic cancer",
                "comparison": "cancerous tissues vs adjacent tissues",
                "source": "Figure 2A",
                "method": "immunohistochemistry",
                "finding": "patients exhibited different levels of FXR expression ranging from negative to strong positive"
            },
            "measures": "[]",
            "outcomes": ""
        }
    ],
    "PMC5687650_6": [
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "Gender",
                "comparison_groups": "Women or Men",
                "metric": "P value",
                "metric_value": "0.175"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.770 (0.528-1.124), 0.175]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "Age",
                "comparison_groups": ">65 years or \u226465 years",
                "metric": "P value",
                "metric_value": "0.163"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.773 (0.537-1.110), 0.163]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "PLR",
                "comparison_groups": "high or low",
                "metric": "P value",
                "metric_value": "0.660"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.922 (0.641-1.325), 0.660]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "NLR",
                "comparison_groups": "high or low",
                "metric": "P value",
                "metric_value": "0.969"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.007 (0.701-1.448), 0.969]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "Post/pre-chemotherapy PLR ratio",
                "comparison_groups": ">1 or \u22641",
                "metric": "P value",
                "metric_value": "0.199"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.272 (0.881-1.837), 0.199]"
        },
        {
            "subject": {
                "analysis_type": "univariate",
                "risk_factor": "Post/pre-chemotherapy NLR ratio",
                "comparison_groups": ">1 or \u22641",
                "metric": "P value",
                "metric_value": "0.001**"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001**]"
        },
        {
            "subject": {
                "analysis_type": "multivariate",
                "risk_factor": "Post/pre-chemotherapy NLR ratio",
                "comparison_groups": ">1 or \u22641",
                "metric": "P value",
                "metric_value": "0.001**"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001**]"
        }
    ],
    "PMC5464866_1": [
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "year": "0"
            },
            "measures": "[number at risk]",
            "outcomes": "[87(49.7%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "year": "2"
            },
            "measures": "[number at risk]",
            "outcomes": "[16(9.1%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "year": "4"
            },
            "measures": "[number at risk]",
            "outcomes": "[6(3.4%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "year": "6"
            },
            "measures": "[number at risk]",
            "outcomes": "[1(0.6%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "year": "0"
            },
            "measures": "[number at risk]",
            "outcomes": "[88(50.3%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "year": "2"
            },
            "measures": "[number at risk]",
            "outcomes": "[9(5.1%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "year": "4"
            },
            "measures": "[number at risk]",
            "outcomes": "[3(1.7%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "year": "6"
            },
            "measures": "[number at risk]",
            "outcomes": "[0(0.0%)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.83]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.78]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "survival rate type": "three year survival rate",
                "confidence interval": "95% CI"
            },
            "measures": "[survival rate]",
            "outcomes": "[0.4288(0.3020~0.6089)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "Low",
                "survival rate type": "five year survival rate"
            },
            "measures": "[survival rate]",
            "outcomes": "[0.3127(0.1776~0.5503)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "survival rate type": "three year survival rate",
                "confidence interval": "95% CI"
            },
            "measures": "[survival rate]",
            "outcomes": "[0.3036(0.1646~0.5600)]"
        },
        {
            "subject": {
                "context": "pancreatic cancer",
                "data type": "survival data",
                "expression": "FXR",
                "group": "High",
                "survival rate type": "five year survival rate"
            },
            "measures": "[survival rate]",
            "outcomes": "[0.2277(0.0989~0.5241)]"
        }
    ],
    "PMC5641200_3": [
        {
            "subject": {
                "AE": "Red blood cells count decreased",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[5 (83)]"
        },
        {
            "subject": {
                "AE": "Red blood cells count decreased",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Red blood cells count decreased",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "AE": "Leukopenia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Leukopenia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Leukopenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "AE": "Leukopenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Neutropenia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[4 (67)]"
        },
        {
            "subject": {
                "AE": "Neutropenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Neutropenia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "AST increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "AST increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "AST increase",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[4 (100)]"
        },
        {
            "subject": {
                "AE": "ALT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[4 (67)]"
        },
        {
            "subject": {
                "AE": "ALT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "ALT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "ALT increase",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (75)]"
        },
        {
            "subject": {
                "AE": "GGT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "GGT increase",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Hypocalcemia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Hyponatremia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Hyponatremia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Hyponatremia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Nausea",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Nausea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "AE": "Nausea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Vomiting",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Vomiting",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Diarrhea",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Diarrhea",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Diarrhea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Diarrhea",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Abdominal pain",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Abdominal pain",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Oral mucositis",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Dyspepsia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Dysgeusia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Dysgeusia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Anorexia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Anorexia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (50)]"
        },
        {
            "subject": {
                "AE": "Alopecia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Alopecia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[4 (67)]"
        },
        {
            "subject": {
                "AE": "Alopecia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Fatigue",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Fatigue",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Fatigue",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (75)]"
        },
        {
            "subject": {
                "AE": "Pneumonitis",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G3"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Peripheral sensory neuropathy",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[3 (50)]"
        },
        {
            "subject": {
                "AE": "Peripheral sensory neuropathy",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Arthralgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[2 (33)]"
        },
        {
            "subject": {
                "AE": "Arthralgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Arthralgia",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        },
        {
            "subject": {
                "AE": "Myalgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G1"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Myalgia",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "LVEF decrease",
                "Dasatinib Dose Level": "Level 1",
                "n": "6",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (17)]"
        },
        {
            "subject": {
                "AE": "Pericardial effusion",
                "Dasatinib Dose Level": "Level 2",
                "n": "4",
                "Grade": "G2"
            },
            "measures": "[n (%)]",
            "outcomes": "[1 (25)]"
        }
    ],
    "PMC5716794_2": [
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "55",
                "optimal_cutoff_values_mm2_s": "1.70",
                "AUC": "0.687",
                "SE": "0.079",
                "CI": "0.575\u22120.785",
                "sensitivity": "89.1",
                "sensitivity_CI": "78.8\u221295.5",
                "specificity": "50.0",
                "specificity_CI": "26.0\u221274.0",
                "PPV": "86.4",
                "NPV": "56.3",
                "ACC": "80.5"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.687, 0.079, 89.1, 50.0, 86.4, 56.3, 80.5]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "82",
                "optimal_cutoff_values_mm2_s": "1.72",
                "AUC": "0.694",
                "SE": "0.077",
                "CI": "0.582\u22120.791",
                "sensitivity": "90.6",
                "sensitivity_CI": "80.7\u221296.5",
                "specificity": "50.0",
                "specificity_CI": "26.0\u221274.0",
                "PPV": "86.6",
                "NPV": "59.9",
                "ACC": "81.7"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.694, 0.077, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "99",
                "optimal_cutoff_values_mm2_s": "1.73",
                "AUC": "0.707",
                "SE": "0.074",
                "CI": "0.596\u22120.802",
                "sensitivity": "90.6",
                "sensitivity_CI": "80.7\u221296.5",
                "specificity": "50.0",
                "specificity_CI": "26.0\u221274.0",
                "PPV": "86.6",
                "NPV": "59.9",
                "ACC": "81.7"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.707, 0.074, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "134",
                "optimal_cutoff_values_mm2_s": "1.74",
                "AUC": "0.731",
                "SE": "0.070",
                "CI": "0.622\u22120.823",
                "sensitivity": "90.6",
                "sensitivity_CI": "80.7\u221296.5",
                "specificity": "50.0",
                "specificity_CI": "26.0\u221274.0",
                "PPV": "86.6",
                "NPV": "59.9",
                "ACC": "81.7"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.731, 0.070, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "152",
                "optimal_cutoff_values_mm2_s": "1.70",
                "AUC": "0.751",
                "SE": "0.067",
                "CI": "0.643\u22120.840",
                "sensitivity": "89.1",
                "sensitivity_CI": "78.8\u221295.5",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "87.7",
                "NPV": "58.9",
                "ACC": "81.7"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.751, 0.067, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "161",
                "optimal_cutoff_values_mm2_s": "1.70",
                "AUC": "0.756",
                "SE": "0.065",
                "CI": "0.649\u22120.844",
                "sensitivity": "89.1",
                "sensitivity_CI": "78.8\u221295.5",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "87.7",
                "NPV": "58.9",
                "ACC": "81.7"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.756, 0.065, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "189",
                "optimal_cutoff_values_mm2_s": "1.75",
                "AUC": "0.770",
                "SE": "0.062",
                "CI": "0.664\u22120.856",
                "sensitivity": "90.6",
                "sensitivity_CI": "80.7\u221296.5",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "87.9",
                "NPV": "62.5",
                "ACC": "82.9"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.770, 0.062, 90.6, 55.6, 87.9, 62.5, 82.9]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "214",
                "optimal_cutoff_values_mm2_s": "1.79",
                "AUC": "0.788",
                "SE": "0.059",
                "CI": "0.684\u22120.871",
                "sensitivity": "92.2",
                "sensitivity_CI": "82.7\u221297.4",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "88.1",
                "NPV": "66.7",
                "ACC": "84.2"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.788, 0.059, 92.2, 55.6, 88.1, 66.7, 84.2]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "223",
                "optimal_cutoff_values_mm2_s": "1.79",
                "AUC": "0.793",
                "SE": "0.058",
                "CI": "0.689\u22120.874",
                "sensitivity": "93.8",
                "sensitivity_CI": "84.8\u221298.3",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "88.3",
                "NPV": "71.6",
                "ACC": "85.4"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.793, 0.058, 93.8, 55.6, 88.3, 71.6, 85.4]"
        },
        {
            "subject": {
                "study_type": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "imaging_technique": "diffusion-weighted imaging (DWI)",
                "measurement_type": "apparent diffusion coefficient (ADC)",
                "ROI_size_mm2": "245",
                "optimal_cutoff_values_mm2_s": "1.79",
                "AUC": "0.800",
                "SE": "0.056",
                "CI": "0.697\u22120.881",
                "sensitivity": "95.3",
                "sensitivity_CI": "86.9\u221299.0",
                "specificity": "55.6",
                "specificity_CI": "30.8\u221278.5",
                "PPV": "88.4",
                "NPV": "76.9",
                "ACC": "86.6"
            },
            "measures": "[AUC, SE, sensitivity, specificity, PPV, NPV, ACC]",
            "outcomes": "[0.800, 0.056, 95.3, 55.6, 88.4, 76.9, 86.6]"
        }
    ],
    "PMC3757392_2": [
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Capan-1",
                "ICC": "++",
                "Flow": "40",
                "Confocal": "++",
                "Do kBq": "170"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[40, ++, 170]"
        },
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Cfpac-1",
                "ICC": "+++",
                "Flow": "500",
                "Confocal": "+++",
                "Do kBq": "140"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[500, +++, 140]"
        },
        {
            "subject": {
                "Vector": "C595:MUC1",
                "Cell line": "Panc-1",
                "ICC": "+++",
                "Flow": "80",
                "Confocal": "+++",
                "Do kBq": "160"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[80, +++, 160]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Capan-1",
                "ICC": "++",
                "Flow": "88",
                "Confocal": "++",
                "Do kBq": "190"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[88, ++, 190]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Cfpac-1",
                "ICC": "+++",
                "Flow": "92",
                "Confocal": "+++",
                "Do kBq": "130"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[92, +++, 130]"
        },
        {
            "subject": {
                "Vector": "394:uPA",
                "Cell line": "Panc-1",
                "ICC": "+++",
                "Flow": "91",
                "Confocal": "+++",
                "Do kBq": "170"
            },
            "measures": "[Flow, Confocal, Do kBq]",
            "outcomes": "[91, +++, 170]"
        },
        {
            "subject": {
                "Vector": "2200-2500",
                "Cell line": "all cells",
                "Do kBq": "2200-2500"
            },
            "measures": "[]",
            "outcomes": "[]"
        }
    ]
}